The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against <i>Clostridioides Difficile</i>

<i>Clostridioides difficile</i> colitis overgrowth occurs when the normal gut microbiome becomes disrupted, often due to antibiotics. Effective treatment remains elusive, due partly to the persistence of its spores in the gut. Natural substances like manuka honey offer an alternative ant...

Full description

Saved in:
Bibliographic Details
Main Authors: Lillian Yu (Author), Reynal Palafox-Rosas (Author), Brian Luna (Author), Rosemary C. She (Author)
Format: Book
Published: MDPI AG, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cc61a944f4784a5a80702f4cacb8dee4
042 |a dc 
100 1 0 |a Lillian Yu  |e author 
700 1 0 |a Reynal Palafox-Rosas  |e author 
700 1 0 |a Brian Luna  |e author 
700 1 0 |a Rosemary C. She  |e author 
245 0 0 |a The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against <i>Clostridioides Difficile</i> 
260 |b MDPI AG,   |c 2020-10-01T00:00:00Z. 
500 |a 10.3390/antibiotics9100684 
500 |a 2079-6382 
520 |a <i>Clostridioides difficile</i> colitis overgrowth occurs when the normal gut microbiome becomes disrupted, often due to antibiotics. Effective treatment remains elusive, due partly to the persistence of its spores in the gut. Natural substances like manuka honey offer an alternative antimicrobial mechanism of action to conventional antibiotics. We investigated the antibiotic activity of manuka honey against 20 <i>C. difficile</i> isolates. The minimum inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBC) of manuka honeys of methylglyoxal (MGO) grades 30<sup>+</sup>, 100<sup>+</sup>, 250<sup>+</sup>, and 400<sup>+</sup> were determined based on broth microdilution. Sporicidal activity was assessed in a range of honey concentrations by enumerating total viable cell and spore counts at 0-96 h after organism inoculation. The MICs of <i>C. difficile</i> ranged from 4% to >30% (<i>w</i>/<i>v</i>). MIC<sub>50</sub> for the four MGO grades were similar at 10-14%. MBC results for the majority of isolates were distributed bimodally at MBC/MIC ratios ≤4 or MBC >30%. Growth kinetics in honey showed total viable cell counts remaining >10<sup>5</sup> colony-forming units (CFU)/mL at all time points, whereas spore counts remained within 1-log of baseline (10<sup>2</sup> CFU/mL) in honey but steadily increased in the drug-free control to >10<sup>5</sup> CFU/mL by 96 h. Manuka honey demonstrated variable inhibitory and bactericidal activity against <i>C. difficile</i>. MGO grade had no noticeable impact on overall MIC distributions or bactericidal activity. Although manuka honey could inhibit spore proliferation, it did not eradicate spores completely. 
546 |a EN 
690 |a methylglyoxal 
690 |a spore 
690 |a <i>C. difficile</i> infection 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 9, Iss 10, p 684 (2020) 
787 0 |n https://www.mdpi.com/2079-6382/9/10/684 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/cc61a944f4784a5a80702f4cacb8dee4  |z Connect to this object online.